Jumpcode Genomics

Jumpcode Genomics

Focus on the signal, not the noise.

Founded 2016

San Diego, United States 15 employees Series B Total: $23.50M Biotechnology, Health Care +1

Jumpcode Genomics is a biotechnology startup with a clear mission embodied in its slogan, "Focus on the signal, not the noise." Founded in 2015 and headquartered in the United States, the company is making waves with its proprietary CRISPRclean® technology. By combining CRISPR-based technology with next-generation sequencing (NGS), Jumpcode Genomics enables scientists to uncover previously unnoticed signals in their samples. This innovative approach not only enhances sensitivity but also broadens the understanding of human biology across fields from research to clinical applications, including infectious diseases and oncology. In January 2021, the company secured a significant $21.00M Series B investment from prominent investors such as Arboretum Ventures, Baird Capital, and LYZZ CAPITAL. This injection of funds attests to the potential and promise seen in Jumpcode Genomics and its revolutionary technology. With a sharp focus on removing unwanted sequences and facilitating greater insights for researchers worldwide, the company stands at the forefront of innovation in the biotechnology and healthcare industries. Jumpcode Genomics is undeniably a disruptive force in genomics, poised for further growth and impact.

Funding Stage	Amount	Investors	Lead Investors	Date
Series B	$21.00M	3	Arboretum Ventures, Baird Capital +1	20 Jan 2021
Venture Round	$2.50M	-		12 Sep 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series B

$21.00M

Arboretum Ventures, Baird Capital +1

20 Jan 2021

Venture Round

$2.50M

12 Sep 2018

FAQ About Jumpcode Genomics

Focus on the signal, not the noise.

Jumpcode Genomics was founded in 2016.

Jumpcode Genomics is headquartered in San Diego, United States.

Jumpcode Genomics operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Genomics, CRISPR, Next-generation Sequencing and Oncology.

Jumpcode Genomics has approximately 15 employees.

Jumpcode Genomics has completed 2 funding rounds, raising a total of $23.50M. The latest funding stage is Series B.

Top alternatives and competitors to Jumpcode Genomics include Resolve Biosciences, Clear Labs, SeqLL, Aniling, Annoroad Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Jumpcode Genomics and Resolve Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Jumpcode Genomics

Funding Rounds & Investors (2)

Jumpcode Genomics Alternatives & Competitors

FAQ About Jumpcode Genomics